Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer

Andreas Eisenhardt1, Ulrich Frey, Monika Tack

  • 1Department of Pharmacology, University Hospital Essen, Hufelandstr. 55, 45122 Essen, Germany. Andreas.Eisenhardt@uni-essen.de

European Urology
|December 8, 2004
PubMed
Abstract

Insights

The chemokine receptor CXCR4 is expressed in bladder cancer cells and promotes metastasis. Targeting CXCR4 may offer new strategies for treating bladder cancer spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The chemokine receptor CXCR4 plays a role in cancer metastasis.
  • Understanding CXCR4's function in bladder cancer is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate CXCR4 expression in bladder cancer cells.
  • To determine the functional activation of CXCR4 and its role in metastasis-related pathways.

Main Methods:

  • Reverse transcription PCR to quantify CXCR4 transcript expression in bladder cancer tissues and cell lines.
  • Stimulation of bladder cancer cell lines (J82, T24) with SDF-1 to assess intracellular calcium, stress fiber formation, chemotaxis, Matrigel invasion, and proliferation.

Main Results:

  • CXCR4 transcripts were detected in normal urothelium, bladder cancer tissues, and cell lines.
  • SDF-1 stimulation induced stress fiber formation, chemotaxis, invasion, and proliferation in bladder cancer cells, independent of intracellular calcium changes.
  • These effects were inhibited by a CXCR4-specific antibody.

Conclusions:

  • CXCR4 is functionally active in bladder cancer cells and contributes to metastatic processes.
  • CXCR4 represents a potential therapeutic target for investigating and treating bladder cancer metastasis in vivo.